FinTrust Capital Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$287K Sell
3,424
-1,000
-23% -$78.8K 0.05% 257
2024
Q2
$341K Buy
4,424
+71
+2% +$5.2K 0.06% 211
2024
Q1
$298K Sell
4,353
-835
-16% -$53.7K 0.06% 227
2023
Q4
$300K Hold
5,188
0.06% 225
2023
Q3
$274K Sell
5,188
-34,468
-87% -$1.81M 0.06% 222
2023
Q2
$1.83M Hold
39,656
0.44% 54
2023
Q1
$1.83M Hold
39,656
0.44% 55
2022
Q4
$1.83M Sell
39,656
-3,377
-8% -$146K 0.44% 55
2022
Q3
$1.77M Buy
43,033
+584
+1% +$23.4K 0.46% 49
2022
Q2
$1.62M Sell
42,449
-877
-2% -$35.7K 0.4% 59
2022
Q1
$1.92M Buy
43,326
+8,032
+23% +$348K 0.44% 52
2021
Q4
$1.5M Sell
35,294
-875
-2% -$36.8K 0.36% 62
2021
Q3
$1.57M Buy
36,169
+2,193
+6% +$97K 0.41% 58
2021
Q2
$1.45M Buy
+33,976
New +$1.43M 0.38% 64
2020
Q4
Sell
-157
Closed -$6 1079
2020
Q3
$6 Hold
157
﹤0.01% 920
2020
Q2
$6K Sell
157
-100
-39% -$3.6K ﹤0.01% 802
2020
Q1
$8K Sell
257
-100
-28% -$3.91K ﹤0.01% 784
2019
Q4
$16K Buy
357
+119
+50% +$4.98K 0.01% 673
2019
Q3
$10K Sell
238
-126
-35% -$5.34K ﹤0.01% 751
2019
Q2
$16K Sell
364
-414
-53% -$15.9K 0.01% 643
2019
Q1
$30K Sell
778
-2,500
-76% -$95.5K 0.01% 498
2018
Q4
$115K Buy
+3,278
New +$119K 0.06% 246

Other funds holding BSX

FinTrust Capital Advisors's BSX Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Boston Scientific (BSX) stake by 23% in Q3 2024, selling an estimated $78.8K and leaving 3,424 shares worth $287K. The position accounts for 0.05% of the portfolio, ranked #257.

FinTrust Capital Advisors first reported a position in BSX in Q4 2018 and has held it in 22 quarters since. The position peaked at $1.92M in Q1 2022. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • FinTrust Capital Advisors held 3,424 shares of Boston Scientific worth $287K as of Q3 2024.
  • FinTrust Capital Advisors sold 1,000 Boston Scientific shares in Q3 2024, an estimated $78.8K.
  • Boston Scientific made up 0.05% of FinTrust Capital Advisors's portfolio in Q3 2024, its #257 holding.
  • FinTrust Capital Advisors first reported a position in Boston Scientific in Q4 2018 and has held it in 22 quarters since.
  • FinTrust Capital Advisors's Boston Scientific position peaked at $1.92M in Q1 2022.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.